Related references
Note: Only part of the references are listed.CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway
Xinxing Wang et al.
Aging-US (2021)
Targeting the CCL2-CCR2 axis in depressive disorders
Katarzyna Curzytek et al.
PHARMACOLOGICAL REPORTS (2021)
Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
Esther Melamed et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of chemokines and chemokine receptors in multiple sclerosis
Li-Yuan Cui et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy
Alan Weiss et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
circMAN1A2 could serve as a novel serum biomarker for malignant tumors
Chun-Mei Fan et al.
CANCER SCIENCE (2019)
Safety of Electroconvulsive Therapy in Treatment-Refractory Depression in the Setting of Multiple Sclerosis
Jennifer Oilgmueller et al.
JOURNAL OF ECT (2019)
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Kristin N. Varhaug et al.
FRONTIERS IN NEUROLOGY (2019)
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
Antoine Yrondi et al.
BRAIN STIMULATION (2018)
Psychiatric comorbidity in multiple sclerosis
S. P. Panda et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2018)
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial
Mazda Adli et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Opinion -: Chemokines:: a new class of neuromodulator?
William Rostene et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Share Paper
